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Background: Vascular dementia is the second most common type of dementia in the United 
States. The underlying association of tobacco and alcohol with vascular dementia is not com-
pletely understood.
Purpose: Determine the relationship of tobacco and alcohol use with the development of 
vascular dementia (VaD).
Methods: This was a matched case-control study of subjects living in Olmsted County, 
MN. Cases of VaD were identified through medical record abstraction using conventionally 
accepted definitions of VaD, using the National Institute of Neurological Disorders and Stroke 
and the Association Internationale pour la Recherche et l’Ensignement en Neurosicences 
  (NINDS-AIRENS) criteria and were matched to controls by gender and age within 3 years 
among persons free of dementia on the index date. Exposure data for alcohol and tobacco 
use were abstracted by trained nurses, along with demographic, lifestyle, cerebrovascular, 
cardiovascular, and vascular comorbid disease characteristics. Matched conditional logistic 
regression for univariate and multivariate evaluation of the association of tobacco and alcohol 
use with VaD was utilized.
Results: Current alcohol exposure was associated with a decreased risk of VaD with an odds 
ratio of 0.48 (95% confidence interval: 0.31–0.74). This protective effect of alcohol was seen in 
men, women, and subjects under 80 years of age. Tobacco use was not associated with VaD in 
univariate and multivariate analysis, and stratified analysis did not reveal any subgroup-specific 
associations between tobacco use and VaD in the study population.
Conclusion: Current alcohol use appears to have protective effects against the development of 
vascular dementia. The effects are more pronounced in subjects under age 80. This may reflect the 
direct vascular effects of alcohol on the vascular system or may represent a surrogate for better 
social or functional status. Previous alcohol use was not protective. Tobacco use was not a risk 
factor for VaD status, which was possibly an indication of survivorship bias in the cohort.
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Introduction
Vascular dementia (VaD) is a common and increasingly recognized illness that has 
some identifiable lifestyle comorbid risk factors. VaD involves cognitive decline with 
underlying pathological lesions of vascular ischemia or occlusion.1 In a Midwestern 
autopsy study, VaD represented the second most common form of dementia, follow-
ing Alzheimer’s disease, and may account for up to 25% of dementia in the United 
States.2 Internationally, there are differences in VaD prevalence. The Japanese suffer 
a higher prevalence of VaD than Americans,3 perhaps demonstrating a cultural or 
ethnic component to the illness. The importance of lifestyle issues in these cultural 
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differences remains incompletely characterized. Many of 
the lifestyle risk factors for vascular dementia have treatable 
components or may be protective. Thus, there is a need to 
understand how lifestyle issues, like tobacco and alcohol use, 
influence the development of vascular dementia.
Despite partial understanding of some of the risk factors 
for stroke, many questions remain about potential risk factors 
for VaD. One cannot assume that the risk factors for stroke 
and VaD are the same. The objective of this study was to 
determine the differences in risk from lifestyle exposures 
between individuals with VaD and controls without VaD. 
We evaluated the exposure to tobacco and alcohol in both 
VaD cases and in the control group. We hypothesized that 
tobacco use was a risk factor, as it is a risk factor for other 
vascular illnesses.4 We further hypothesized that alcohol was 
protective against dementia.5 To answer these questions, we 
undertook a matched case-control study in patients with well-
documented VaD compared to age-matched controls.
Method
Study design
This study utilizes a retrospective, matched case-control 
analysis of patients living within Olmsted County, MN. 
The Mayo Clinic medical record system has over 70 years 
of medical records data from over 6 million patients and has 
been widely used for epidemiological studies.6
Setting
The Mayo Clinic is the largest health care provider in 
  Southeastern, MN, providing care at the primary,   secondary, 
and tertiary levels. The time ranges included cases and con-
trols from inpatient and outpatient medical care records from 
1994–2002. Exposures were included for all times prior to 
determination of case or control status. All visits to Mayo 
Clinic providers are captured via physician notes, electronic 
medical records, and through clinical billing in an electronically 
integrated medical record system. These records are compre-
hensive and follow the patient throughout their life. Paper and 
electronic information sources were available and complete for 
all patients seen during the time of study initiation.
Study subjects
Population
The US Census estimated Olmsted County’s population to 
be 124,277 in 2000.7 Educationally, 38.9% had a bachelor’s 
degree or higher compared to 27.4% in the US at large. Of 
the Olmsted County population, 90.3% were white, 4.3% 
Asian and 2.7% black or African American.7
Cases
Cases were defined as patients with a clinically documented 
diagnosis of vascular dementia. Records were screened 
for any one of 40 diagnoses suggestive of dementia. The 
incident cases of VaD were drawn from these records. 
The diagnostic information to make the determination was 
obtained from medical histories, neuroimaging studies, and 
clinical   diagnoses. The diagnosis of dementia was based 
on the National Institute of Neurological Disorders and 
Stroke and the Association Internationale pour la   Recherche 
et l’Ensignement en Neurosicences (NINDS-AIREN) cri-
teria for VaD.8 The date of diagnosis of VaD for the case 
represented the index date for each case-control pair. If a 
control developed dementia during the time frame of the 
study, after having been selected as a control, he or she was 
included as a case with a uniquely matched control. Status as 
a previous control was retained relative to that individual’s 
matched case.
Controls
Controls were dementia-free in the medical records with the 
corresponding case index data and were matched 1:1 for age 
(±2 years), gender, and Mayo Clinic registration number. 
Matching for registration number allowed for similar access 
times to the medical system.
Exclusion criteria
Individuals with any diagnosis of dementia before 1994 were 
excluded from the study. Patients who refused authorization 
for medical records review were also excluded.
Exposure variables
The lifestyle exposure variables were tobacco and alcohol 
use. We used a dichotomous representation of ever (yes/no), 
previous (yes/no), and current (yes/no) for tobacco use. The 
specific types of tobacco use were as described: cigarette 
use, cigar use, pipe, and chew/smokeless tobacco use. The 
subjects also reported the number of years of tobacco use. 
Alcohol use had a dichotomous representation of ever 
(yes/no), previous (yes/no), and current (yes/no). The subjects 
self-reported the number of years of alcohol use. The amounts 
of alcohol or tobacco were also recorded. Specific types of 
alcohol included beer, wine, and hard liquor. All lifestyle 
information was based on self-report from the patient. Patient 
personal history obtained from the prior date closest to the 
index date was used.
The characteristics of the cohort were also collected. 
Comorbid medical illnesses were defined based upon   clinical 
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diagnosis or by guidelines. Cerebrovascular disease was 
defined as medically diagnosed history of stroke and/or tran-
sient ischemic attacks (TIA). Stroke or TIA was defined as 
ever or never, prior to the index date. Myocardial infarction 
was evaluated clinically and was defined as ever or never, 
prior to the index date. Congestive heart failure, angina, and 
atrial fibrillation were defined as ever or never, prior to the 
index date. Hypertension was defined based upon JNC VII 
criteria of systolic blood pressure (SBP) greater than 140,9 
prior to the index date. The exposure used was the presence 
or absence of hypertension. Diabetes was diagnosed clini-
cally and was defined as ever or never, prior to the index 
date. Educational years were determined based upon the last 
year of education.
Data acquisition
The primary information abstracted included medical diag-
noses and surgical information, which was coded using 
the International Classification of Disease adapted code 
for hospitals (H-ICDA). Alcohol and smoking informa-
tion were collected using a self-reported questionnaire that 
patients completed prior to a medical evaluation. A trained 
nurse abstractor obtained and recorded the information on 
an electronic spreadsheet (Excel, v 2003; Microsoft Corp, 
Redmond, WA). The abstractor was blinded to the study 
hypothesis and was not involved with any analysis of data. 
Further information on the case and control exposures was 
obtained from the Mayo Clinic records-linkage system.
We attempted to reduce bias by blinding the data abstrac-
tors to the purpose of the study. The subjects reported alcohol 
and smoking use in a clinical setting; thus, there was potential 
for under-reporting its use. Recall bias would be minimized 
because the questionnaires asked about recent, as well as 
previous use. Despite these efforts, the effects of bias were 
likely present.
Sample size
All available subjects who met the criteria within the time 
frame described were enrolled within the case-control study, 
because of the relatively uncommon nature of the case status 
(VaD). Two hundred and five matched pairs were included 
within the analysis.
Data analysis
Simple descriptive statistics were calculated for demographic 
and exposure data among cases and controls, as well as for 
gender strata. The primary method of comparison between 
cases and controls utilized the odds ratio as a surrogate for 
relative risk with 95% confidence intervals (95% CI). We 
utilized conditional logistic regression for analysis of the 
exposure variables between cases and controls. Subjects 
with missing information were excluded from analysis. We 
performed stratified conditional logistic regression for both 
gender and for age (,80 years and 80 years and above). 
All analyses were performed on Epi Info (v 3.5; Centers for 
Disease Control, Atlanta, GA).
Results
In the study, 1736 potential subjects were identified using the 
initial evaluation from their medical records. From this group, 
the investigators identified 205 cases of VaD using standard 
criteria as noted above. The records of 1531 patients did not 
meet the criteria after medical record review. The schematic 
distribution is shown in Figure 1. The 205 pairs included 
121 pairs of female subjects and 84 pairs of male subjects 
with an overall mean age of 81.9 years (SD: 7.79 years). The 
average length of educational involvement was 12.3 years 
(SD: 3.25 years). Comparing males and females, males had 
a lower age of 78.2 years (SD: 7.88 years) compared to 
84.1 years (SD: 6.86 years) in females. The average educa-
tional achievement did not differ between the genders. The 
most common comorbid health condition was hypertension 
in the cohort, with 72.9% of cases and controls having hyper-
tension. The full demographic and descriptive information 
of the overall cohort is noted in Table 1. Lifestyle exposures 
are listed in Table 2. These tables indicate the missing data. 
Missing data levels were high for specific alcohol type, and 
for the remainder of the variables between 8 and 17 were 
missing. The absolute numbers of exposures in cases and 
controls are listed.
Tobacco exposure (current, previous, ever) was not dif-
ferent between cases and controls in the univariate analysis 
1736 subjects with potential
dementia by records abstraction 
205 cases with confirmed
vascular dementia  
1231 ineligible (did
not meet VaD criteria) 
205 age/gender matched controls
(paired VaD cases and controls) 
Figure 1 Flow of subjects till final determination of cohort.
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in the overall cohort. Specific alcohol type did not provide 
protection or serve as a risk in the overall cohort (Table 3). 
In the gender subgroup analysis, there was a similar protec-
tive effect of current alcohol use in both females, with an 
odds ratio of 0.45 (95% CI: 0.25–0.84), and males, with 
an odds ratio of 0.52 (95% CI: 0.28–0.96). The remaining 
types of alcohol use (previous or ever) were not signifi-
cant in the gender subgroup analysis. The only additional 
significant value was a slight protective effect of wine use 
in women with an odds ratio of 0.52 (95% CI: 0.27–0.99). 
In the age subgroup analysis, current alcohol use did not 
achieve significance in adults under 80 years of age. It was 
significant in adults over 80 with an odds ratio of 0.31 (95% 
CI: 0.15–0.66). All remaining factors for alcohol use were 
not significantly different between the overall cohort and the 
age stratified cohort.
The duration of smoking or alcohol use did not show a 
difference between VaD cases and controls. The number of 
years of tobacco use was not associated with VaD status and 
was similar in both cases and controls. The number of years 
of alcohol use was also not associated with VaD between 
cases and controls. These findings were also found in the 
subgroup analysis by gender for both alcohol and tobacco use. 
Stratification by age did not provide additional information 
on different types of alcohol use or tobacco use.
Discussion
Vascular dementia remains a growing public health issue 
as our society faces the demographic tsunami of an aging 
populace. In the US, the old (.65 years) and the oldest old 
(.80 years), will continue to expand into 2040, and stand 
as the fastest growing sections of the population.10 The 
diagnosis of VaD remains somewhat challenging; however, 
the NINDS-AIREN criteria currently stand as the accepted 
standard for VaD diagnosis. Agreement among different 
providers using NINDS-AIREN criteria has been moderate to 
good.11 In numerous longitudinal studies, increasing age has 
a strong association with increased prevalence of VaD.12,13 
In our study, we found that tobacco use did not contribute 
to an increased risk of VaD, while current alcohol use was 
protective.
Tobacco use
We evaluated tobacco use by looking at current, previous, 
and ever use, while also looking for a dose effect. All of 
these risk variables were non-significant, with current use 
of tobacco having the highest but nonsignificant odds ratio 
of 1.67 (95% CI: 0.73–3.81). We evaluated tobacco use by 
Table 1 Demographic overview of cases of vascular dementia 








  Male (%) 168 (41.0) 84 (41.0) 84 (41.0)
  Age in years (SD) 81.9 (7.79) 82.1 (7.73) 81.6 (7.85)
  Education in years (SD) 12.3 (3.25) 12.0 (3.35) 12.6 (3.13)
    Body mass index,  
kg/m2 (SD)
26.2 (5.02) 25.8 (4.50) 26.5 (5.40)
  Obese, yes/no (%) 175 (53.4) 76 (51.4) 99 (55.0)
History of comorbid health conditions
  Stroke (%) 148 (37.0) 133 (65.8) 15 (7.6)
  TIA (%) 80 (20.0) 66 (32.7) 14 (7.1)
  CHF (%) 88 (21.8) 60 (29.3) 28 (14.1)
  Angina (%) 130 (32.2) 70 (34.1) 60 (30.3)
  Atrial fibrillation (%) 88 (21.8) 58 (28.3) 30 (15.1)
  Previous MI (%) 78 (19.3) 41 (20.0) 37 (18.6)
  Hypertension (%) 291 (72.9) 161 (80.1) 130 (65.7)
  Diabetes (%) 101 (24.7) 64 (31.2) 37 (18.1)
Abbreviations:  VaD,  vascular  dementia;  TIA,  transient  ischemic  attack;  CHF, 
congestive heart failure; MI, myocardial infarction.
Table 2 Alcohol and tobacco exposure in a cohort of 410 subjects
Exposure Cases Controls Missing data
Alcohol use
  Alcohol, current 53/199 86/198 13
  Alcohol, previous 149/199 153/194 17
  Alcohol, ever 149/199 154/195 16
  Beer 56/167 59/166 77
  Wine 48/167 54/166 77
  Hard liquor 75/168 94/166 76
Tobacco use
  Tobacco, current 17/198 11/199 13
  Tobacco, previous 112/201 111/201 8
  Tobacco, ever 112/201 111/201 8
  Cigar 7/201 8/199 10
  Pipe 12/201 9/199 10
  Chew/snuff 4/201 3/199 10
in the overall cohort. There also was no difference between 
different types of tobacco and VaD status. Lastly, there 
was no association between years of tobacco use and case 
or control status. These findings are noted in Table 3. We 
stratified the cohort by gender (male and female), and we did 
not find differences in tobacco exposure between cases and 
controls. Lastly, we stratified the analysis by age (under and 
over 80 years of age) and again did not find a difference in 
tobacco use (current, previous, ever). Tobacco frequency or 
amount of tobacco use also was not significantly different 
between VaD cases and controls.
Current alcohol use exposure was protective with an 
odds ratio of 0.48 (95% CI: 0.31–0.74). Previous alcohol 
use and ever alcohol use did not have a significant effect 
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tobacco type and did not find an association between specific 
tobacco type and VaD status. Subgroup analysis did not 
show any significant association between tobacco use and 
VaD. However, there were some interesting trends that were 
noted. In the younger and female populations, there was no 
association between tobacco status and case status. Men who 
had previously or ever used tobacco seemed to have some 
trends toward higher odds ratios, but these trends did not 
reach significance. The older population (80+ years old) also 
seemed to have a trend toward a higher odds ratio of VaD. 
Our study population represents a primarily white popula-
tion which differs from other studies. The novel findings in 
this study include a lack of associations with different age or 
gender subgroups and with different tobacco products. The 
lack of a consistent relationship between VaD and tobacco 
use may reflect survivorship bias in that patients who smoke 
and survived to develop VaD are different to those who died. 
The apparent protective effects of smoking in Alzheimer’s 
disease and Parkinson disease have been attributed to sur-
vivorship bias.14
The results of previous studies on the effect of smoking 
and VaD have been mixed. Smoking stands as an important 
risk factor for stroke15 and may be a potential risk factor for 
VaD. However, the direct evidence that smoking affects 
VaD has been unimpressive. A recent meta-analysis of the 
relationship between VaD and smoking had a nonsignificant 
odds ratio of 1.35 (95% CI: 0.90–2.02).16 In a Chinese study 
of six communities, there was an association of VaD with 
smoking with a relative risk of 1.98 (95% CI: 1.53–3.12).17 
In the Honolulu aging study, there was no significant 
relationship between current, former, and never smokers 
and the development of VaD.18 Thus, there is still debate on 
this issue, with our study showing no relationship between 
tobacco use and VaD.
Alcohol use
In our study, current alcohol use was a protective factor with 
an odds ratio of 0.48 (95% CI: 0.31–0.74). Current alcohol 
use was protective in the overall cohort as well as within the 
subgroup analysis of females and in those patients ,80 years 
of age. The protective effect seemed strongest in cases 
younger than 80 years, with an odds ratio of 0.31 (95% CI: 
0.15–0.66). Within the overall cohort, there did not appear to 
be a significant association with either alcohol type or previ-
ous alcohol use and VaD. In the subgroups, women seemed to 
have a protective effect with wine use; however, the remain-
ing subgroups did not have significant values. It appears that 
current alcohol use, as opposed to previous use, seems to be 
protective. This could reflect a direct cardiovascular effect of 
alcohol upon vascular risks. Mild-to-moderate alcohol intake 
is associated with improved endothelial function.19 It could 
also represent better social support in those individuals who 
drink socially with other individuals.20 The individuals who 
drink alcohol also possess a higher functional status than 
those who do not drink.21 However, in previous studies, even 
after adjustment for social economic status and functional 
Table 3 Univariate analysis of demographic and lifestyle risk factors for 205 matched pairs of vascular dementia cases and healthy 
controls
Odds ratio Lower 95% CI Upper 95% CI P value
Demographics
  Age 1.39 1.13 1.69 0.002*
  Education in years (SD) 1.00 1.00 1.001 0.87
Lifestyle alcohol use
  Alcohol, current 0.48 0.31 0.74 0.001*
  Alcohol, previous 0.80 0.49 1.31 0.38
  Alcohol, ever 0.80 0.49 1.31 0.38
  Beer, ever 0.88 0.50 1.55 0.67
  Wine, ever 0.78 0.48 1.24 0.29
  Hard liquor, ever 0.64 0.40 1.04 0.07
  Number of years drinking 0.99 0.98 1.01 0.31
Tobacco use
  Tobacco, current 1.67 0.73 3.81 0.23
  Tobacco, previous 1.00 0.66 1.52 1.00
  Tobacco, ever 1.00 0.66 1.52 1.00
  Cigar, ever 0.88 0.32 2.41 0.80
  Pipe, ever 1.33 0.56 3.16 0.51
  Chew/snuff, ever 1.00 0.20 4.95 1.00
  Number of years smoking 1.01 1.00 1.02 0.12
Note: *Reached statistical significance.
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  status, those individuals who have a moderate intake of alco-
hol have increased longevity.21 In our study, if a patient suffers 
VaD, it is quite possible that they do not have the means or 
methods of obtaining alcohol for current use.
Alcohol use has had a mixed picture with vascular   disease 
and with memory problems. Alcohol has a neurotoxic effect 
upon the central nervous system and in excess, can cause 
alcohol-related dementia.22 In a pooled meta-analysis, 
light-to-moderate alcohol use had a small protective effect 
for the development of any type of dementia with a relative 
risk of 0.75 (95% CI: 0.57–0.98). Heavy alcohol use was 
not protective and was a risk in this meta-analysis.23 VaD 
as a specific illness was not evaluated in this meta-analysis. 
In a large Chinese cohort study, mild-to-moderate alcohol 
consumption had a larger protective effect for VaD risk 
with a hazard ratio of 0.31 (95% CI: 0.19–0.51) compared 
to Alzheimer’s disease with a hazard ratio of 0.63 (95% CI: 
0.55–0.72). Heavy alcohol use was not protective.24 In the 
Canadian Study of Health and Aging, there was no associa-
tion between weekly alcohol use (beer, wine, or spirits) and 
the development of VaD. The odds ratios varied between 
alcohol type; however, the lowest odds ratio was for beer, 
at 0.61 (95% CI: 0.31–1.26) and was not significant.25 Thus, 
the relationship with alcohol use has not shown a consistently 
protective effect in preventing VaD; however, in aggregate, 
the studies do trend toward a protective effect.
Study limitations
There are some limitations with the study. In this matched 
case-control study, one has the advantages of robust medi-
cal records with defined criteria. The agreement between 
electronic abstraction and nurse abstraction tends to favor 
nurse abstraction, which was performed in this study.26 
There exists the possibility of missing information which 
can be an inherent challenge with case-control studies. For 
the primary outcomes of tobacco or alcohol use, the range 
of missing information was low at 8–17 (2%–4%) missing 
records per exposure variable. The type of tobacco or alcohol 
type had more missing records. However, the records were 
fairly complete and the subjects filled out questionnaires 
yearly. The biggest challenge involves the self-report of 
lifestyle issues such as alcohol use.27 There may have been 
a tendency to under-report alcohol or tobacco use to the 
provider. This could mitigate any real effects or differences 
between VaD cases and the controls. In case-control studies, 
the issue of recall bias is also an important one. The lifestyle 
questionnaires are asked yearly; thus, the risk of recall bias 
is reduced.
The generalizability of this study to other populations 
remains an important question. The population of the study 
was a largely English-speaking white population. The ability 
to generalize this to other populations and other countries 
might be problematic. The weight of the evidence that   alcohol 
is protective in vascular disease is growing. However, there 
are potentially economic, social, and cultural issues that may 
influence the type and amount of alcohol taken. Thus, the find-
ings of this study are encouraging, but one must be cautious if 
the local population differs greatly from the one studied.
Conclusions
Vascular dementia remains a common and daunting prob-
lem that affects many adults in developed and developing 
countries. This matched case-control study found that current 
alcohol use may actually reflect a potential protective effect 
of alcohol on the vascular system. Tobacco use (current, 
previous, ever), along with type of tobacco use, was not 
associated with VaD status. This lack of association may be 
related to a survivorship bias. There clearly remains further 
work to be performed to fully understand all of the risks for 
vascular dementia in the older population.
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